AAT score based on pretreatment indicators predicts outcomes in unresectable HCC patients treated with TACE, Sintilimab, and Bevacizumab - Quiz - MDSpire

AAT score based on pretreatment indicators predicts outcomes in unresectable HCC patients treated with TACE, Sintilimab, and Bevacizumab

  • By

  • Wanying Qin

  • Xudong Fei

  • Renfang Shi

  • Yuchen Zhou

  • Jiajie Tang

  • Yizhe Liu

  • Yi Zhu

  • Liya Suo

  • Weijia Liao

  • June 10, 2026

  • 0 min

Share

Original Source(s)

AAT score based on pretreatment indicators predicts outcomes in unresectable HCC patients treated with TACE, Sintilimab, and Bevacizumab

  • by Wanying Qin, Xudong Fei, Renfang Shi, Yuchen Zhou, Jiajie Tang, Yizhe Liu, Yi Zhu, Liya Suo, Weijia Liao

  • June 10, 2026

Related Content

Development and validation of a multiparametric MRI-based radiomics nomogram for the tripartite discrimination of primary benign, primary malignant, and metastatic lumbar spinal tumors

Heroes in motion – a six-year quality report and patient evaluation of a real-world exercise therapy program in pediatric oncology

Harnessing Vδ1+ T cells for next-generation immunotherapy: from mechanistic insights to clinical translation